![(FILES) In this file photo taken on April 30, 2020 Gilead Sciences headquarters sign is seen in Foster City, California. The experimental drug remdesivir has been authorized by US regulators for emergency use against COVID-19, President Donald Trump announced on May 1, 2020. / AFP / Josh Edelson](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/BKQ7SXS3OVPC4VHYDPQ6B5TZCE.jpg?smart=true&auth=13bb73092dc730f8ebc73e256ae7f42aaf24bc2adc3d5ce26c92d15a94af8af2&width=400&height=225)
The experimental drug remdesivir has been authorised by the US and Japan for emergency use against Covid-19. AFP
The experimental drug remdesivir has been authorised by the US and Japan for emergency use against Covid-19. AFP
Coronavirus: Iran-linked hackers targeted drug maker Gilead
The US company is behind remdesivir, the only treatment to have so far proven effective against the virus